Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Condition: Atrial Fibrillation
This page shows you your search results in order of relevance. This is page number 15.
Order by Relevance | Date
Total 320 results found since Jan 2013.
Contemporary Practice and Optimising Referral Pathways for Implantable Cardiac Monitoring for Atrial Fibrillation after Cryptogenic Stroke
Diagnosing atrial fibrillation (AF) in patients following Cryptogenic stroke (CS) has therapeutic implications that can reduce the risk of further strokes. However, it's indolent and paroxysmal nature makes this challenging. Prolonged rhythm monitoring using implantable loop recorders (ILRs) can significantly increase the AF detection rate in the clinical trial paradigm. Whether this can be translated to real-world practice is unknown. An evaluation of referral pathways, workload and real-world efficacy may help select patients and inform service development.
Source: Journal of Stroke and Cerebrovascular Diseases - May 8, 2022 Category: Neurology Authors: Nikhil Ahluwalia, Adam Graham, Shohreh Honarbakhsh, Tillana Tarkas, Samuel Martin, Chris Monkhouse, Malcolm Finlay, Mark J. Earley, Roser Icart, Oliver Spooner, Arvind Chandratheva, Richard J. Schilling Source Type: research
Atrial fibrillation is associated with poor long-term outcome after mechanical thrombectomy for anterior large vessel occlusion stroke
Atrial fibrillation (AF) is one of the leading causes of acute ischemic stroke (AIS). The aim of our study was to determine the influence of AF on the long-term outcome of patients with AIS due to anterior circulation large vessel occlusion (LVO) treated with mechanical thrombectomy (MT).
Source: Journal of Stroke and Cerebrovascular Diseases - September 30, 2022 Category: Neurology Authors: Mirjana Ždraljević, Tatjana Pekmezović, Predrag Stanarčević, Ivan Vukašinović, Ivana Berisavac, Marko Ercegovac, Filip Vitošević, Dragoslav Nestorović, Vladimir Cvetić, Višnja Padjen, Maja Stefanović-Budimkić, Tamara Švabić Medjedović, De Source Type: research
Embolic infarct topology differs between atrial fibrillation subtypes and embolic stroke of undetermined source
The lack of superiority of anticoagulation over antiplatelet therapy in embolic stroke of undetermined source (ESUS) may be in part due to the misclassification of radiographic ESUS patterns as cardioembolic. In this imaging analysis, we sought to differentiate clinical and radiographic patterns of ESUS patients from patterns in patients with a highly probable cardioembolic source.
Source: Journal of Stroke and Cerebrovascular Diseases - September 18, 2022 Category: Neurology Authors: Jared Wolfe, Solomon Oak, Justin Tiongson, Nicholas Vigilante, Emma Frost, Mary Penckofer, Lauren Thau, Zachary Iezzi, Pratit Patel, James E. Siegler Source Type: research
Changing trends and factors influencing anticoagulant use in patients with acute ischemic stroke and NVAF at discharge in the NOACs era
We sought to explore the trends and influencing factors of the use of anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation (NVAF) at discharge in the era of novel oral anticoagulants (NOACs).
Source: Journal of Stroke and Cerebrovascular Diseases - December 3, 2022 Category: Neurology Authors: Sufang Xue, Xue Qiu, Min Wei, Qi Kong, Jing Dong, Qiujia Wang, Fangyu Li, Haiqing Song Source Type: research
Ability of the DANCAMI to predict the risk ischemic stroke and mortality in patients with atrial fibrillation/flutter
Comparison of the danish comorbidity index for acute myocardial infarction (DANCAMI), the charlson comorbidity index (CCI), the elixhauser comorbidity index (ECI), and the CHA2DS2-VASc score to predict ischemic stroke, cardiovascular mortality, and all-cause mortality after atrial fibrillation/flutter.
Source: Journal of Stroke and Cerebrovascular Diseases - July 13, 2023 Category: Neurology Authors: Kasper Bonnesen, Uffe Heide-J ørgensen, Henrik Toft Sørensen, Morten Schmidt Source Type: research
Factors affecting reasonable duration of continuous electrocardiographic monitoring to detect atrial fibrillation in acute ischemic stroke
To examine the reasonable duration of continuous electrocardiographic monitoring (CEM) to detect AF at acute ischemic stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - May 13, 2023 Category: Neurology Authors: Chie Tsunetoshi, Kenzo Tsunetoshi, Osamu Komori, Yoshifumi Higashino, Makoto Isozaki, Yoshikazu Arai, Hiroshi Arai, Shintaro Yamada, Hidetaka Arishima, Mika Hasegawa, Kenichiro Kikuta Source Type: research
Diagnosis of atrial fibrillation in young patients with ischemic stroke: A systematic review and meta-analysis
The recommended cardiac rhythm evaluation to determine the etiology of ischemic stroke (IS) is similar in all patients regardless of their age and includes an electrocardiogram and at least a 24-hour heart rhythm monitoring. However, it is known that the main causes of IS vary according to patients ’ age. There is a higher preponderance of arterial dissections and patent foramen ovale in younger patients, while atrial fibrillation (AF) is more common in older patients.
Source: Journal of Stroke and Cerebrovascular Diseases - August 30, 2023 Category: Neurology Authors: Joana V ítor, Gonçalo V. Bonifácio, Ana Catarina Fonseca Source Type: research
Outcome of 312 Japanese Patients with Carotid Endarterectomy and Factors Associated with Cardiovascular Events—A Single-center Study in Japan
Background: There have only been a few reports regarding the outcomes and risk factors after CEA. To clarify the factors associated with outcome in patients with carotid stenosis who underwent carotid endarterectomy (CEA), we investigated cardiovascular events and mortality in the Kyushu Medical Center in Japan.Methods: We consecutively registered patients with significant carotid stenosis who had CEA performed over 10 years and compared the incidences of stroke, myocardial infarction, and death. On admission, we evaluated medical records for stroke risk factors, including hypertension, diabetes mellitus, hypercholesterol...
Source: Journal of Stroke and Cerebrovascular Diseases - May 30, 2013 Category: Neurology Authors: Toshiyasu Ogata, Tooru Inoue, Yasushi Okada Tags: Original Articles Source Type: research
Impact of Atrial Fibrillation and Inadequate Antithrombotic Management on Mortality in Acute Neurovascular Syndrome
Conclusions: Patients with AF have more severe stroke and higher mortality than stroke patients without AF. Adherence to the antithrombotic treatment guidelines for the prevention of AF-related cardioembolic strokes is suboptimal. Further studies are needed to evaluate the impact of current antithrombotic treatment guidelines on mortality.
Source: Journal of Stroke and Cerebrovascular Diseases - August 25, 2014 Category: Neurology Authors: Jukka T. Saarinen, Harri Rusanen, Niko Sillanpää, Heini Huhtala, Heikki Numminen, Irina Elovaara Tags: Original Articles Source Type: research
Early Hospitalization of Patients with TIA: A Prospective, Population-based Study
Conclusions: These findings may help clinicians to estimate the TIA prognosis in patients who were hospitalized early with TIA.
Source: Journal of Stroke and Cerebrovascular Diseases - November 19, 2012 Category: Neurology Authors: Mohamed Al-Khaled, Jürgen Eggers Tags: Original Articles Source Type: research
Efficacy of NeuroFlo Device in Treatment of Patients with Atrial Fibrillation
We report subgroup analyses of outcomes in SENTIS patients with a history or new diagnosis of AF. Among patients with AF, those treated with NeuroFlo demonstrated significant improvement over those not treated for multiple end points: global efficacy end point (P = .030), modified Rankin Scale (mRS) score 0-2 versus 3-6 (P = .029), and stroke-related mortality (P = .015). There was a significant improvement in global end point for those aged 60 years or older (P = .042) and 80 years or older (P = .017), with a trend toward improvement for age 70 years or older (P = .055), and significant improvement in those wh...
Source: Journal of Stroke and Cerebrovascular Diseases - February 14, 2014 Category: Neurology Authors: Gary L. Bernardini, Peter D. Schellinger, Alex Abou-Chebl, Kevin Cockroft, Ashfaq Shuaib, Rishi Sheorajpanday, Souvik Sen, Hans-Christoph Diener, Ronen R. Leker, Natan M. Bornstein Tags: Original Articles Source Type: research
The Impact of Prior Antithrombotic Status on Cerebral Infarction in Patients with Atrial Fibrillation
Background: Anticoagulation effectively prevents cardioembolic stroke in atrial fibrillation (AF) patients, whereas it is less effective than antiplatelet therapy (AT) in noncardioembolic stroke prevention. We hypothesized that the ischemic lesion pattern and vascular patency would differ according to the antithrombotic treatment status in AF patients.Methods: The medical records of 1078 acute ischemic stroke patients with AF were retrospectively reviewed. Patients were classified according to medication at stroke onset: (1) optimal anticoagulation (OAC; international normalized ratio [INR] 1.7-3.0; n = 36); (2) suboptim...
Source: Journal of Stroke and Cerebrovascular Diseases - August 11, 2014 Category: Neurology Authors: Bum Joon Kim, Hyo Jin Kim, Youngrok Do, Ju-Hun Lee, Kwang-Yeol Park, Jae-Kwan Cha, Hahn-Young Kim, Jee-Hyun Kwon, Kyung Bok Lee, Dong-Eog Kim, Sang-Won Ha, Sung-Il Sohn, Sun U. Kwon Tags: Original Articles Source Type: research
The Association Between Atrial Fibrillation and Poststroke Seizures is Influenced by Ethnicity and Environmental Factors
This study assessed whether ethnicity affects the association between AF and poststroke seizure (PSS) development. We hypothesized that Royal Melbourne Hospital ([RMH] Melbourne) patients will have significantly higher incidence of AF-related PSS than in the Jinling Hospital (Nanjing) population.
Source: Journal of Stroke and Cerebrovascular Diseases - July 21, 2018 Category: Neurology Authors: Jillian Naylor, Leonid Churilov, Benjamin Johnstone, Ruibing Guo, Yunyun Xiong, Miriam Koome, Ziyi Chen, Arthur Thevathasan, Ziyuan Chen, Xinfeng Liu, Patrick Kwan, Bruce C.V. Campbell Source Type: research
The Use of Oral Anticoagulants in Patients with Atrial Fibrillation in the Emergency Department
Atrial Fibrillation is the leading cause of embolic stroke, yet less than half of high-risk patients with atrial fibrillation are on adequate stroke prevention with oral anticoagulants. Guidelines for the primary prevention of stroke recognize the emergency department as a location for physicians to identify atrial fibrillation and initiate anticoagulants. We sought to compare anticoagulant prescription rates in patients with atrial fibrillation in various provider settings to identify opportunities for improvement in cardioembolic stroke prevention.
Source: Journal of Stroke and Cerebrovascular Diseases - January 26, 2020 Category: Neurology Authors: Hope Hua, Nicole Sur, Jungwon Choi, Sai Polineni, Lilly Lee, Seemant Chaturvedi Source Type: research
Vitamin K Antagonist–associated Intracerebral Hemorrhage: Lessons from a Devastating Disease in the Dawn of the New Oral Anticoagulants
Conclusions: VKA-associated ICH presents in a particularly vulnerable population and has a poor prognosis that may be reliably predicted by several clinicoradiologic features.
Source: Journal of Stroke and Cerebrovascular Diseases - August 19, 2013 Category: Neurology Authors: Marta Suárez-Pinilla, Ángeles Fernández-Rodríguez, Lorena Benavente-Fernández, Sergio Calleja-Puerta Tags: Original Articles Source Type: research
